InterCure Ltd. (INCR)

NASDAQ: INCR · Real-Time Price · USD
1.750
+0.010 (0.57%)
Nov 4, 2024, 12:53 PM EST - Market open
0.57%
Market Cap 82.45M
Revenue (ttm) 72.42M
Net Income (ttm) -17.43M
Shares Out 47.77M
EPS (ttm) -0.38
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 24,099
Open 1.740
Previous Close 1.740
Day's Range 1.740 - 1.770
52-Week Range 1.010 - 3.720
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 12, 2024

About INCR

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel. [Read more]

Sector Healthcare
Founded 1994
Employees 270
Stock Exchange NASDAQ
Ticker Symbol INCR
Full Company Profile

Financial Performance

Financial numbers in ILS Financial Statements

News

Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company

InterCure Ltd. INCR has shown resilience in its H1 2024 performance despite facing significant challenges, according to equity research by Pablo Zuanic of Zuanic & Associates.

7 weeks ago - Benzinga

InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million

NEW YORK and HERZLIYA, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) -- InterCure  Ltd . (NASDAQ: INCR) (TASE: INCR) ("InterCure" or the "Company") is pleased to announce its financial and operating results ...

2 months ago - GlobeNewsWire

InterCure Announces Expansion of its Strategic partnership with Cookies to Germany

NEW YORK & HERZLIYA, Israel--(BUSINESS WIRE)--InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading vertically integrated medical cannabis company outsid...

2 months ago - Business Wire

InterCure: A Cannabis Industry Leader Still Flying Under The Radar

InterCure is a leading pharmaceutical/medical cannabis company based in Israel and a global leader outside North America. Despite the damage the Hamas attack and the state of war in Israel caused, the...

4 months ago - Seeking Alpha

InterCure to Participate in Canaccord Genuity's 8th Annual Global Cannabis Conference

NEW YORK & HERZLIYA, Israel--(BUSINESS WIRE)--InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc), the leading medical cannabis company outside of North America, today announced that it will part...

5 months ago - Business Wire

InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million

NEW YORK & HERZLIYA, Israel--(BUSINESS WIRE)--InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) ("InterCure" or the "Company") today announced results for the full year ending December 31, 2023. All amounts ...

6 months ago - Business Wire

InterCure: Bargain Israel Cannabis Play

InterCure Ltd. has faced challenges due to the conflict with Hamas, including not having access to a prime facility in Israel, but is expected to recover. The cannabis market in Israel is still limite...

6 months ago - Seeking Alpha

InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million

NEW YORK & HERZLIYA, Israel--(BUSINESS WIRE)---- $INCR #CANNABIS--InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) ("InterCure" or the “Company”) today announced preliminary results for the full year of 202...

7 months ago - Business Wire

InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint

NEW YORK & HERZLIYA, Israel--(BUSINESS WIRE)---- $INCR #CANNABIS--InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company outside ...

8 months ago - Business Wire

PESG Industry Updates: Germany's Cannabis Act and Its Impact on the Medical Cannabis Landscape

LONDON--(BUSINESS WIRE)---- $INCR #CannG--The PESG Research has released an industry update following the regulatory shifts in Germany. Germany is expected to pass the Cannabis Act today (Friday), her...

9 months ago - Business Wire

InterCure Provides an Update Regarding Nir Oz Facility

NEW YORK, and HERZLIYA, Israel, Feb. 13, 2024 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Compan y"), the leading medical cannabis company in Isra...

9 months ago - GlobeNewsWire

InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain

NEW YORK, and HERZLIYA, Israel, Jan. 31, 2024 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Compan y"), the leading medical cannabis company in Isra...

9 months ago - GlobeNewsWire

InterCure Wins Cannolam Arbitration Proceeding

NEW YORK and HERZLIYA, Israel , Oct. 31, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Compan y"), the leading medical cannabis company in Isra...

1 year ago - GlobeNewsWire

InterCure Provides an Update Regarding the Security Situation in Israel

NEW YORK, and HERZLIYA, Israel, Oct. 17, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Compan y"), the leading medical cannabis company in Isra...

1 year ago - GlobeNewsWire

InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY

Achieved record revenues of NIS 209 million ($ 7 5 million) 1 for the first half of 2023

1 year ago - GlobeNewsWire

InterCure: Leader In Israel's Growing Medical Cannabis Market

In mid-August, InterCure, one of the leaders in the global medical cannabis market, will publish financial results for the 2nd quarter of 2023. According to the Ministry of Health, the consumption of ...

1 year ago - Seeking Alpha

InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE

NEW YORK and TORONTO and HERZLIYA, Israel, July 10, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the "Compan y"), announced today that...

1 year ago - GlobeNewsWire

InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

NEW YORK and TORONTO and HERZLIYA, Israel, June 09, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the "Compan y"), reports today that, ...

1 year ago - GlobeNewsWire

InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference

Mr. Rabinovitch is one of the global cannabis senior executives to participate Mr. Rabinovitch is one of the global cannabis senior executives to participate

1 year ago - GlobeNewsWire

InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY

Achieved record revenues of $40 million for the first quarter Annualized revenue run rate of $159 million Adjusted EBITDA(1) of $6 Million Strong balance sheet with over $45 million cash and Net curre...

1 year ago - GlobeNewsWire

InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary

NEW YORK and TORONTO and HERZLIYA, Israel, April 25, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Compan y"), the leading medica...

1 year ago - GlobeNewsWire

InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries

Leading Global Pharmaceutical Cannabis Company, InterCure, signed an initial collaboration agreement with legendary boxer, entrepreneur and cannabis advocate Mike Tyson's premium cannabis brand Leadin...

1 year ago - GlobeNewsWire

InterCure: How Bright Is The Company's Future In 2023

Despite continued market challenges for the cannabis industry, InterCure's revenue continues to grow year-on-year and, more importantly, quarter-on-quarter to NIS 105.6 million in Q4 2022. InterCure's...

1 year ago - Seeking Alpha

InterCure Ltd. (INCR) Q4 2022 Earnings Call Transcript

InterCure Ltd. (NASDAQ:INCR) Q4 2022 Earnings Conference Call April 4, 2023 4:30 PM ET Company Participants Alexander Rabinovitch - CEO & Director Amos Cohen - CFO Conference Call Participants Vivien...

1 year ago - Seeking Alpha

InterCure Reschedules 2022 Full Year Results Conference Call

NEW YORK, TORONTO, and HERZLIYA, Israel, April 03, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) announced today that i...

1 year ago - GlobeNewsWire